INFECTION PREVENTION RESOURCE GUIDE


Affairs & Intensive Care in North America, Dräger. “Generally speaking, respiratory care practi- tioners are responsible for the safe and effective reprocessing of ventila- tors in the ICU between patients,” Coombs said.


properly manage PPE, including how to put on, use, store and remove (which has his- torically been an issue even before COVID), was highlighted this past year yet again, particularly given the high mortality rate.” Examining HAIs prior to COVID-19, the


Edwin Coombs


“For the past year during COVID, special attention has been paid to ways in which this reprocessing can be streamlined while remaining safe and effective.”


For patients in the hospital's care for longer periods of time, SARS-CoV-2, con- sequently, increases the risk of contraction of HAIs and, therefore, necessitates extra safety precautions, explains Kalvin Yu, M.D., FIDSA, Senior Medical Director, BD. “A recent BMC study demonstrated that, of more than 140,000 patients tested, those with COVID had a higher rate of potential HAIs, showing that essentially SARS-CoV-2 was associ- ated with higher rates of certain types of hospital- onset infections, greater antimicrobial usage and


Kalvin Yu


extended hospital and ICU length of stay,”4 Yu indicated. “Additionally, resources normally diverted to education on how to


National Human Genome Research Insti- tute (NHGRI) reported that “researchers studied administrative data from 133,304 patients who stayed in National Health Service (NHS) hospitals in Oxfordshire, U.K. for at least 48 hours between 2011 and 2015…Using the data, the team could predict subsequent infection for bacterial and viral pathogens that commonly cause hospital-acquired infections: methicillin- resistant Staphylococcus aureus (MRSA), Escherichia coli, Pseudomonas aerugi- nosa, Clostridium difficile and norovirus. These pathogens are usually transmitted either through direct contact, contami- nated surfaces or contaminated food and drinks. “For all five pathogens, the researchers found that patients were most likely to be infected if they spent more than 24 hours in the presence of a potentially infected person…According to the study results, if healthcare workers had tested patients based on the duration of exposure to known or suspected cases, new cases could be caught up to a day before they actually


were detected. The researchers believe that implementing such an approach will help prevent the spread of hospital- acquired infections and vastly reduce the cost burden.”5


Instrument reprocessing has become another responsibility on the IP side, observes Theresa “Terri” Kunsman, Senior Product Manager for CDS (Cleaning, Disinfection, and Sterilization), Olympus America, Inc.


“Infection prevention managers have been taking a much more active role in understanding and following end-to- end endoscope reprocessing processes and re-evaluating protocols,” Kunsman indicated. “This additional oversight and day-to-day management of processes have led to additional investments being made in reprocessing tools and technologies, as well as education and training programs.”


Preparing for future roles How can IP practices succeed and enhance patient safety in the future? Peter Veloz, Chief Exec-


utive Officer, UltraViolet Devices, Inc. (UVDI), sug- gests, “Expandable infec- tion prevention protocols that can be scaled rapidly in the event of patient


Peter Veloz


A Solution That Delivers


Tru-D’s patented Sensor360® technology calculates a measured, accurate UVC dose that destroys pathogens throughout a room from one position and one cycle.1


technology calculates a pathogens throughout a room from one position and


Adding Tru-D’s enhanced UVC disinfection technology to your cleaning protocols has been shown to provide a cleaner hospital environment for patients.2,3


technology to your cleaning protocols has been shown If you are interested in learning more, visit us at tru-d com/proven. tru-d.com/proven.


TRU-D.COM • 800.774.5799 36 June 2021 • HEALTHCARE PURCHASING NEWS • hpnonline.com


1 Anderson, D., et al (2013). Decontamination of Targeted Pathogens from Patient Rooms Using an Automated Ultraviolet-C-Emitting Device. Infection Control and Hospital Epidemiology, 34(5), 466-471.2. 2 Mahida, N, et al (2013). First UK evaluation of an automated Ultraviolet-C room decontamination device (Tru-D). Journal of Hospital Infection, 05(005), 1-4.3. Sexton, D., Anderson, D., et al (2017). (QKDQFHG WHUPLQDO URRP GLVLQIHFWLRQ DQG DFTXLVLWLRQ DQG LQIHFWLRQ FDXVHG E\ PXOWLGUXJ UHVLVWDQW RUJDQLVPV DQG &ORVWULGLXP GLɝ FLOH WKH %HQHfi WV RI (QKDQFHG 7HUPLQDO 5RRP 'LVLQIHFWLRQ VWXG\ D cluster-randomised, multicentre, crossover study. The Lancet. 389(10071), 805-814

Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66